- Home
- TRVI vs NUW Comparison
TRVI vs NUW Comparison
Compare TRVI & NUW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- NUW
- Stock Information
- Founded
- TRVI 2011
- NUW 2008
- Country
- TRVI United States
- NUW United States
- Employees
- TRVI N/A
- NUW N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- NUW Investment Managers
- Sector
- TRVI Health Care
- NUW Finance
- Exchange
- TRVI Nasdaq
- NUW Nasdaq
- Market Cap
- TRVI 211.4M
- NUW 246.1M
- IPO Year
- TRVI 2019
- NUW N/A
- Fundamental
- Price
- TRVI $4.51
- NUW $13.59
- Analyst Decision
- TRVI Strong Buy
- NUW
- Analyst Count
- TRVI 8
- NUW 0
- Target Price
- TRVI $9.31
- NUW N/A
- AVG Volume (30 Days)
- TRVI 4.0M
- NUW 45.3K
- Earning Date
- TRVI 11-06-2024
- NUW 01-01-0001
- Dividend Yield
- TRVI N/A
- NUW 3.66%
- EPS Growth
- TRVI N/A
- NUW N/A
- EPS
- TRVI N/A
- NUW N/A
- Revenue
- TRVI N/A
- NUW N/A
- Revenue This Year
- TRVI N/A
- NUW N/A
- Revenue Next Year
- TRVI N/A
- NUW N/A
- P/E Ratio
- TRVI N/A
- NUW N/A
- Revenue Growth
- TRVI N/A
- NUW N/A
- 52 Week Low
- TRVI $1.26
- NUW $12.45
- 52 Week High
- TRVI $4.60
- NUW $14.44
- Technical
- Relative Strength Index (RSI)
- TRVI 75.02
- NUW 31.07
- Support Level
- TRVI $2.36
- NUW $13.55
- Resistance Level
- TRVI $4.60
- NUW $13.99
- Average True Range (ATR)
- TRVI 0.33
- NUW 0.10
- MACD
- TRVI 0.21
- NUW -0.04
- Stochastic Oscillator
- TRVI 92.46
- NUW 5.66
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About NUW Nuveen AMT-Free Municipal Value Fund
Nuveen AMT-Free Municipal Value Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax by investing in a portfolio of municipal obligations. The fund predominantly invests in long-term municipal bonds, corporate bonds, short-term municipal bonds, and other assets.